• 2022
  Erdmann D, Contreras J, Le Meur RA, Vitorge B, Saverat V, Tafit A, Jallet C, Cadet-Daniel V, Bon C, Phansavath P, Ratovelomanana-Vidal V, Jeltsch A, Vichier-Guerre S, Guijarro JI, Arimondo PB, , Identification of Chemical Probes Targeting MBD2., ACS Chem Biol 2022.
• 2021
  Corentin BON, Yang SI, Melanie PERNAK, Magdalena Barbachowska, Eva Levi-Acobas, Veronique Cadet Daniel, Corinne Jallet, Dusan Ruzic, Nemanja Djokovic,Teodora Djikić, Katarina Nikolic, Ludovic Halby, , Paola B Arimondo, Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein, Bon, C.et al. Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein. Molecules 2021, 26 (17), 5300. https://doi.org/10.3390/molecules26175300..
• 2021
  , Direct Synthesis of Allyl Amines with 2‐Nitrosulfonamide Derivatives via the Tsuji‐Trost Reaction, Bon, C. et al. L. Direct Synthesis of Allyl Amines with 2-Nitrosulfonamide Derivatives via the Tsuji-Trost Reaction. ChemistryOpen n/a (n/a). https://doi.org/10.1002/open.202100147..
• 2021
  Nardella F, Halby L, Dobrescu I, Viluma J, Bon C, Claes A, Cadet-Daniel V, Tafit A, Roesch C, Hammam E, Erdmann D, Mairet-Khedim M, Peronet R, Mecheri S, Witkowski B, Scherf A, Arimondo PB, , Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites., J Med Chem 2021 07; 64(14): 10403-10417.
• 2020
  Corentin BON, Ludovic Halby, Paola B. Arimondo, Bisubstrate inhibitors: the promise of a selective and potent chemical inhibition of epigenetic ‘writers’, Epigenomics, Sep. 2020.
• 2020
  CorentinBon,YangSi, Paola B.Arimondo, Chapter 4 – Targeting DOT1L for mixed-lineage rearranged leukemia, Histone Modifications in Therapy, Translational Epigenetics 2020.
• 2019
  Bon C, Erdmann D, Halby L, Arimondo PB, , [Chemical targeting of DNA and histone methylation in cancer: Novelties, hopes and promises]., Bull Cancer 2019 Oct; 106(10): 823-833.
• 2019
  , Espoirs et promesses de la méthylation de l’ADN et des histones comme cibles anticancéreuses, .
• 2018
  Zhang D, Markoulides MS, Stepanovs D, Rydzik AM, El-Hussein A, Bon C, Kamps JJAG, Umland KD, Collins PM, Cahill ST, Wang DY, von Delft F, Brem J, McDonough MA, Schofield CJ, , Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases., Bioorg Med Chem 2018 07; 26(11): 2928-2936.
• 2017
  Daly HC, Sampedro G, Bon C, Wu D, Ismail G, Cahill RA, O'Shea DF, , BF2-azadipyrromethene NIR-emissive fluorophores with research and clinical potential., Eur J Med Chem 2017 Jul; 135(): 392-400.